Genetics
Elderly men carrying a CETP mutation trend toward the lowest heart disease rates in a 7-year Honolulu Heart Program follow-up (J Lipid Res 2004)
Original title: A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly
Since the relationship between HDL-cholesterol (HDL-C) and coronary heart disease (CHD) incidence is less clear in the elderly than in middle age, and controversy remains over whether CETP deficiency and its associated HDL-C rise are protective or, via impaired reverse cholesterol transport, detrimental, this study followed 2340 men aged 71-93 in the Honolulu Heart Program for 7 years. Age-adjusted CHD incidence was significantly lower in men with high versus low HDL-C. After adjustment for age, hypertension, smoking, and total cholesterol, the relative risk of CHD for men with HDL-C 60 mg/dL or higher versus below 40 mg/dL was 0.6. Men carrying a CETP mutation had the lowest CHD rates of any group, though this difference did not reach statistical significance. The authors conclude HDL-C remains an important CHD risk factor in the elderly, and whether CETP mutation carriage offers additional protection warrants further investigation.
Original abstract
High density lipoprotein cholesterol (HDL-C) levels are inversely associated with the incidence of coronary heart disease (CHD) in middle-aged individuals; in the elderly, the association is less clear. Genetic factors, including variations in the cholesteryl ester transfer protein (CETP) gene, play a role in determining HDL-C levels. Controversy remains about whether CETP deficiency and the resultant rise in HDL-C are antiatherogenic, or whether CETP has the opposite effect due to its role in reverse cholesterol transport. In a seven-year follow-up of 2340 men aged 71-93 in the Honolulu Heart Program, the age-adjusted CHD incidence rates were significantly lower in men with high versus low HDL-C levels. After adjustment for age, hypertension, smoking, and total cholesterol, the relative risk of CHD for those with HDL-C levels >or=60 mg/dl, compared with those with HDL-C levels <40 mg/dl, was 0.6. Men with a CETP mutation had the lowest rates of CHD, although this was not statistically significant. These data indicate that HDL-C remains an important risk factor for CHD in the elderly. Whether a CETP mutation offers additional protection against CHD warrants further investigation.
Summary written by cetpinhibition.org from the published abstract; figures as published. Page updated 19 August 2026. Methods.